Cardiac Structure and Function in Patients with Cystic Fibrosis

NCT06084468 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2025-03-13

No results posted yet for this study

Summary

In a prospective observational cohort study (n = 100), the investigators aim to assess the correlation between cardiac biomarkers, advanced echocardiography and cystic fibrosis genotype and severity and determine whether these are prognostic markers of heart disease in patients suffering from cystic fibrosis (CF).

Conditions

  • Cystic Fibrosis
  • Cystic Fibrosis-related Diabetes
  • Cystic Fibrosis, Pulmonary
  • Cystic Fibrosis of Pancreas
  • Cystic Fibrosis Gastrointestinal Disease
  • Cystic Fibrosis Modifier 1
  • Left Ventricular Dysfunction
  • Heart Failure
  • Heart Failure, Systolic
  • Heart Failure, Diastolic
  • Myocardial Infarction
  • Stroke
  • Heart Diseases

Sponsors & Collaborators

  • Copenhagen University Hospital, Denmark

    collaborator OTHER
  • Herlev and Gentofte Hospital

    lead OTHER

Principal Investigators

  • Tor Biering-Sørensen, Professor MD PhD MPH · Department of Cardiology, Department of Biomedical Sciences, Herlev and Gentofte University Hospital, University of Copenhagen

  • Susanne D Poulsen, MD DMSc · Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital Rigshospitalet, University of Copenhagen

  • Daniel Faurholt-Jepsen, MD PhD · CF Centre Copenhagen University Hospital Rigshospitalet

  • Terese L Katzenstein, MD PhD DMSc · CF Centre Copenhagen University Hospital Rigshospitalet

  • Tacjana Pressler, MD · CF Centre Copenhagen University Hospital Rigshospitalet

  • Rebekka F Thudium, MD PhD · CF Centre Copenhagen University Hospital Rigshospitalet

  • Lisa S Duus, MD · Department of Cardiology, Department of Biomedical Sciences, Herlev and Gentofte University Hospital, University of Copenhagen

  • Maria Dons, MD · Department of Cardiology, Department of Biomedical Sciences, Herlev and Gentofte University Hospital, University of Copenhagen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-03-01
Completion
2032-03-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06084468 on ClinicalTrials.gov